iCoat Medical AB
Peder Waern has a diverse work experience spanning over several companies and roles. Peder is the Co-Founder and CEO of iCoat Medical AB since April 2021 and previously served as a Co-Founder of the same company from 2018 to April 2021. Peder is also the Co-Founder and Executive Chairman of Expo Pay since March 2021 and Expo Stories since September 2020. Prior to their entrepreneurial ventures, they worked at Northstream, part of Accenture, as a Project Manager and Senior Management Consultant from May 2018 to April 2021, and as a Management Consultant from February 2017 to May 2018. Peder also worked as an Investment Manager at Serendipity Professionals from October 2014 to February 2017, and as a Management Consultant at EY from August 2013 to October 2014. Peder briefly worked as a Management Consultant at Greenwich Consulting (Acquired by EY Advisory) as well. Additionally, Peder has prior experience as an Internal Consultant on short-term contracts at Atlas Copco and Bluefish Technologies Group in 2012.
Peder Waern's education history is as follows:
- In 2022, Peder attended StyrelseAkademin and obtained a certification as a certified board professional with a focus on board work.
- In 2013, they studied Finance and Financial Management Services at Harvard University.
- From 2011 to 2013, Peder pursued a Master's degree in Management of International Business at Uppsala University.
- From 2007 to 2010, they obtained a Bachelor of Arts (B.A.) degree in business at Uppsala University.
- In 2006, Peder took an independent course in Rhetoric A at Uppsala University.
- In 2005, they completed an intensive certificate program in English Language and Literature at Frances King School of English.
- Peder received a high school degree specializing in Natural Sciences with additional focus on ice-bandy as an elective choice from Lundellska skolan in 2003.
Additionally, Peder holds several certifications including a CEFR test in English at C2 level from the Common European Framework of Reference for Languages in 2013, a TOEFL exam with a score of 114/120 in 2010, and a Certificate of Proficiency in English (CPE) at the License Level 2 (Highest) from the University of Cambridge in 2005.
This person is not in any teams
iCoat Medical AB
iCoat Medical is a clinical stage, immunotherapy company focusing on reducing and preventing ischemia reperfusion injuries by developing novel pharmaceutical products. The company is one of the world’s leading R&D-centered organizations within innate immunology and is systematically expanding its pipeline using its proprietary coating-technology platform. iCoat Medical’s lead candidate TUM012 is developed to improve the outcome of organ transplantations. iCoat Medical’s unique ex-vivo coating of the grafts has the ambition of being an integral part in the transplant procedures of tomorrow. iCoat Medical has operations in Uppsala, Lund and Malmö, and is headquartered in Stockholm.